Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-16-131273

Chief Executive Officer acquired 15,772 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Anzalone Christopher Richard Chief Executive Officer 2016-06-30 Option exercise +15,772 $5.09 $80,279 1,117,233 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Anzalone Christopher Richard Chief Executive Officer 2016-06-30 Option exercise · Common Stock Warrant −15,772 0 D: show line 2 in the form
Loading xslF345X03/doc4.xml…